Reaction

Abdominal Rigidity reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,665 reports · 66 co-occurring drugs

As of the last recalculation, Abdominal Rigidity appears in 2,665 FAERS reports alongside 66 co-occurring drug terms. The strongest observed disproportionality signal is QUININE (PRR 21.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Quinine	23	21.1	21.2
Diltiazem Hydrochloride Extended-Release Tablets	21	14.5	14.5
Cholestyramine	21	13.7	13.7
Octreotide Acetate	41	10.6	10.6
Hyoscyamine Sulfate	12	10.2	10.3
Fam-Trastuzumab Deruxtecan-Nxki	12	9.3	9.3
Midazolam Hydrochloride	31	9.1	9.1
Dicyclomine Hydrochloride	16	8.8	8.8
Midazolam	26	8.1	8.1
Lanreotide Acetate	8	8.0	8.0
Sorafenib	21	8.0	8.0
Lactulose	37	7.6	7.6
Nitrofurantoin	16	7.6	7.6
Nitrofurantoin (Monohydrate/Macrocrystals)	16	7.5	7.5
Erythromycin	17	7.1	7.1
Aprepitant	16	6.8	6.8
Propofol	31	6.7	6.7
Fluticasone Propionate Nasal	25	6.5	6.5
Pertuzumab	21	6.1	6.1
Teduglutide	10	5.8	5.8
Acetaminophen And Codeine	9	5.8	5.8
Loperamide Hydrochloride And Dimethicone	23	5.6	5.6
Abaloparatide	21	5.6	5.6
Regorafenib	8	5.4	5.4
Vedolizumab	58	5.4	5.4
Niraparib	15	5.3	5.3
Rotigotine	9	4.9	4.9
Rifampicin	6	4.6	4.6
Pancrelipase	22	4.5	4.5
Fexofenadine	9	4.3	4.3
Irinotecan Hydrochloride	7	4.3	4.3
Selexipag	14	4.2	4.3
Linezolid	16	4.2	4.2
Fosaprepitant Dimeglumine	7	4.0	4.0
Fondaparinux Sodium	4	3.9	3.9
Instalax Polyethylene Glycol 3350	6	3.8	3.8
Dexlansoprazole	20	3.8	3.8
Teriparatide	50	3.5	3.5
Nintedanib	14	3.5	3.5
Riociguat	14	3.4	3.4
Risankizumab-Rzaa	33	3.2	3.2
Docetaxel Anhydrous	27	3.2	3.2
Docetaxel	27	3.2	3.2
Trastuzumab	27	3.1	3.1
Fentanyl Citrate	7	3.1	3.1
Linaclotide	10	2.9	2.9
Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose	3	2.9	2.9
Glecaprevir And Pibrentasvir	4	2.8	2.8
Sevoflurane	3	2.8	2.8
Naltrexone Hydrochloride And Bupropion Hydrochloride	3	2.7	2.8
Abemaciclib	7	2.7	2.7
Rifaximin	7	2.6	2.6
Pazopanib Hydrochloride	9	2.6	2.6
Tirzepatide	48	2.3	2.3
Dimethyl Fumarate	36	2.3	2.3
Dulaglutide	24	2.1	2.1
Orlistat	7	2.1	2.1
Velpatasvir And Sofosbuvir	3	1.8	1.8
Pegfilgrastim	22	1.7	1.7
Patiromer	3	1.7	1.7
Ledipasvir And Sofosbuvir	4	1.6	1.6
Levonorgestrel	41	1.6	1.6
Galcanezumab-Gnlm	6	1.5	1.5
Relugolix	4	1.3	1.3
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	5	1.3	1.3
Nirmatrelvir And Ritonavir	7	1.0	1.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.